Long-lasting Protection in Brain Trauma by Endotoxin Preconditioning

Overview

Journal J Cereb Blood Flow Metab

Publisher Sage Publications

Specialties Cardiology & Vascular Diseases
Endocrinology
Neurology

Date 2011 Apr 7

PMID 21468087

Citations 44

Authors

Luca Longhi

Raffaella Gesuete

Carlo Perego

Fabrizio Ortolano

Noemi Sacchi

Pia Villa

Nino Stocchetti

Maria-Grazia De Simoni

Affiliations

Soon will be listed here.

Abstract

We investigated the occurrence of endotoxin (lipopolysaccharide, LPS) preconditioning in traumatic brain injury (TBI), evaluating the time window of LPS-induced protection, its persistence, and the associated molecular mechanisms. Mice received 0.1 mg/kg LPS or saline intraperitoneally and subsequently TBI (by controlled cortical impact brain injury) at various time intervals. Mice receiving LPS 3, 5, or 7 days before TBI showed attenuated motor deficits at 1 week after injury compared with mice receiving saline. Those receiving LPS 5 days before injury had also a reduced contusion volume (7.9±1.3 versus 12±2.3 mm(3)) and decreased cell death. One month after injury, the protective effect of LPS on contusion volume (14.5±1.2 versus 18.2±1.2 mm(3)) and neurologic function was still present. Traumatic brain injury increased glial fibrillary acidic protein, CD11b, CD68, tumor necrosis factor-α, interleukin (IL)-10, and IL-6 mRNA expression 24 hours after injury. Lipopolysaccharide administered 5 (but not 9) days before injury increased the expression of CD11b (233%) and of interferon β (500%) in uninjured mice, while it reduced the expression of CD68 (by 46%) and increased that of IL-6 (by 52%) in injured mice. Lipopolysaccharide preconditioning conferred a long-lasting neuroprotection after TBI, which was associated with a modulation of microglia/macrophages activity and cytokine production.

Citing Articles

Innate immune sensors and regulators at the blood brain barrier: focus on toll-like receptors and inflammasomes as mediators of neuro-immune crosstalk and inflammation.

Acioglu C, Elkabes S J Neuroinflammation. 2025; 22(1):39.

PMID: 39955600 PMC: 11829548. DOI: 10.1186/s12974-025-03360-3.

Administration of monophosphoryl lipid A shortly after traumatic brain injury blocks the following spatial and avoidance memory loss and neuroinflammation.

Hooshmand M, Sadeghi M, Asoodeh A, Pourbadie H, Mehni M, Sayyah M Sci Rep. 2024; 14(1):29408.

PMID: 39592660 PMC: 11599587. DOI: 10.1038/s41598-024-80331-3.

Systemic Inflammation Decreases Initial Brain Injury but Attenuates Neurite Extension and Synapse Formation during the Repair of Injured Brains.

Gaire S, Yang H, Dumre M, Lee E, Park S, Joe E Exp Neurobiol. 2024; 33(5):251-262.

PMID: 39568181 PMC: 11581824. DOI: 10.5607/en24018.

Toll-Like Receptor 1/2 Postconditioning by the Ligand Pam3cys Tempers Posttraumatic Hyperexcitability, Neuroinflammation, and Microglial Response: A Potential Candidate for Posttraumatic Epilepsy.

Khoshkroodian B, Javid H, Pourbadie H, Sayyah M Inflammation. 2024; .

PMID: 39044002 DOI: 10.1007/s10753-024-02109-z.

Deplete and repeat: microglial CSF1R inhibition and traumatic brain injury.

Boland R, Kokiko-Cochran O Front Cell Neurosci. 2024; 18:1352790.

PMID: 38450286 PMC: 10915023. DOI: 10.3389/fncel.2024.1352790.

References

Faden A, Stoica B . Neuroprotection: challenges and opportunities. Arch Neurol. 2007; 64(6):794-800. DOI: 10.1001/archneur.64.6.794. View

Saatman K, Feeko K, Pape R, Raghupathi R . Differential behavioral and histopathological responses to graded cortical impact injury in mice. J Neurotrauma. 2006; 23(8):1241-53. DOI: 10.1089/neu.2006.23.1241. View

Penkowa M, Moos T, Carrasco J, Hadberg H, Molinero A, Bluethmann H . Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice. Glia. 1999; 25(4):343-57. View

Troglio F, Echart C, Gobbi A, Pawson T, Pelicci P, De Simoni M . The Rai (Shc C) adaptor protein regulates the neuronal stress response and protects against cerebral ischemia. Proc Natl Acad Sci U S A. 2004; 101(43):15476-81. PMC: 524437. DOI: 10.1073/pnas.0403283101. View

Rosenzweig H, Lessov N, Henshall D, Minami M, Simon R, Stenzel-Poore M . Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice. Stroke. 2004; 35(11):2576-81. DOI: 10.1161/01.STR.0000143450.04438.ae. View

Umscheif G, Umschwief G, Shein N, Alexandrovich A, Trembovler V, Horowitz M . Heat acclimation provides sustained improvement in functional recovery and attenuates apoptosis after traumatic brain injury. J Cereb Blood Flow Metab. 2009; 30(3):616-27. PMC: 2949134. DOI: 10.1038/jcbfm.2009.234. View

Yamakami I, McIntosh T . Effects of traumatic brain injury on regional cerebral blood flow in rats as measured with radiolabeled microspheres. J Cereb Blood Flow Metab. 1989; 9(1):117-24. DOI: 10.1038/jcbfm.1989.16. View

Capone C, Frigerio S, Fumagalli S, Gelati M, Principato M, Storini C . Neurosphere-derived cells exert a neuroprotective action by changing the ischemic microenvironment. PLoS One. 2007; 2(4):e373. PMC: 1847533. DOI: 10.1371/journal.pone.0000373. View

Stahel P, Shohami E, Younis F, Kariya K, Otto V, Lenzlinger P . Experimental closed head injury: analysis of neurological outcome, blood-brain barrier dysfunction, intracranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines. J Cereb Blood Flow Metab. 2000; 20(2):369-80. DOI: 10.1097/00004647-200002000-00019. View

10.

Shein N, Grigoriadis N, Alexandrovich A, Simeonidou C, Spandou E, Tsenter J . Differential neuroprotective properties of endogenous and exogenous erythropoietin in a mouse model of traumatic brain injury. J Neurotrauma. 2008; 25(2):112-23. DOI: 10.1089/neu.2007.0358. View

11.

Longhi L, Saatman K, Fujimoto S, Raghupathi R, Meaney D, Davis J . Temporal window of vulnerability to repetitive experimental concussive brain injury. Neurosurgery. 2005; 56(2):364-74. DOI: 10.1227/01.neu.0000149008.73513.44. View

12.

Dixon C, Kochanek P, Yan H, Schiding J, Griffith R, Baum E . One-year study of spatial memory performance, brain morphology, and cholinergic markers after moderate controlled cortical impact in rats. J Neurotrauma. 1999; 16(2):109-22. DOI: 10.1089/neu.1999.16.109. View

13.

Gidday J . Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci. 2006; 7(6):437-48. DOI: 10.1038/nrn1927. View

14.

Ortolano F, Colombo A, Zanier E, Sclip A, Longhi L, Perego C . c-Jun N-terminal kinase pathway activation in human and experimental cerebral contusion. J Neuropathol Exp Neurol. 2009; 68(9):964-71. DOI: 10.1097/NEN.0b013e3181b20670. View

15.

Longhi L, Perego C, Ortolano F, Zanier E, Bianchi P, Stocchetti N . C1-inhibitor attenuates neurobehavioral deficits and reduces contusion volume after controlled cortical impact brain injury in mice. Crit Care Med. 2008; 37(2):659-65. DOI: 10.1097/CCM.0b013e318195998a. View

16.

Rosenzweig H, Minami M, Lessov N, Coste S, Stevens S, Henshall D . Endotoxin preconditioning protects against the cytotoxic effects of TNFalpha after stroke: a novel role for TNFalpha in LPS-ischemic tolerance. J Cereb Blood Flow Metab. 2007; 27(10):1663-74. DOI: 10.1038/sj.jcbfm.9600464. View

17.

Storini C, Rossi E, Marrella V, Distaso M, Veerhuis R, Vergani C . C1-inhibitor protects against brain ischemia-reperfusion injury via inhibition of cell recruitment and inflammation. Neurobiol Dis. 2005; 19(1-2):10-7. DOI: 10.1016/j.nbd.2004.11.001. View

18.

Nawashiro H, Tasaki K, Ruetzler C, Hallenbeck J . TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. J Cereb Blood Flow Metab. 1997; 17(5):483-90. DOI: 10.1097/00004647-199705000-00001. View

19.

Marsh B, Stevens S, Packard A, Gopalan B, Hunter B, Leung P . Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3. J Neurosci. 2009; 29(31):9839-49. PMC: 2946887. DOI: 10.1523/JNEUROSCI.2496-09.2009. View

20.

Suzuki S, Tanaka K, Suzuki N . Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects. J Cereb Blood Flow Metab. 2008; 29(3):464-79. DOI: 10.1038/jcbfm.2008.141. View